HOME 2018-02-06T18:21:34+00:00

Welcome to Medical Innovation in Context (MedInContext)

MedInContext is a medical consultancy supporting biotech companies and healthcare providers (HCPs)
in medical affairs planning and strategy.

RECENT POSTS

Immunotherapy and lung cancer – An Update from the ELCC 2017

Immunotherapy and lung cancer – An Update from the ELCC 2017

Immunotherapy in lung cancer has been a topic of very high interest and promise for several years now. Since the
Read More
ALK-rearranged NSCLC – An update from the ELCC 2017

ALK-rearranged NSCLC – An update from the ELCC 2017

Numerous educational presentations, oral abstracts and satellite symposia (sponsored by industry) about ALK+ NSCLC were part of ELCC 2017. The development
Read More
EGFR mutation positive NSCLC – An update from the ELCC May 5-8

EGFR mutation positive NSCLC – An update from the ELCC May 5-8

Most educational sessions at the ELCC about EGFRm+ NSCLC began with the fact that the EGF receptor is a cancer
Read More
European Lung Cancer Congress in Geneva (May 5-8)

European Lung Cancer Congress in Geneva (May 5-8)

This year’s European Lung Cancer Congress (ELCC) was a great opportunity to get a complete update and overview of new
Read More